The Trump administration pledged this week to substantially reduce the high prices Americans commonly pay for their prescription drugs.
Its a promise that will undoubtedly come up short.
While some of the proposals are sound, others are unlikely to move the needle.
Trump speaking at a White House press briefing on January 30.© Joshua Sukoff via Shutterstock
The second round of negotiations involves 15 drugs and will conclude this year, with discounts arriving in 2028.
So if drug prices are truly cut, it would represent a genuine accomplishment.
In the meantime, his HHS has actually made it harder for people on Medicare to afford these medications.
Earlier this month, however, the Trump administrationdroppedthis proposal.
A Staggering Number of U.S.
In the executive order, Trump pledged to align the treatment of these two drug types in the program.
But even these proposals are undermined by actions the White House has taken elsewhere.
And if were truly unlucky, some drugs could become even more expensive soon enough.
News from the future, delivered to your present.
